Prosecution Insights
Last updated: November 15, 2026

Nutrition & Biosciences USA

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Nutrition & Biosciences USA has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 6 distinct examiners and 5 distinct art units, indicating broad examiner coverage with limited technical grouping overlap.

PACKARD, BENJAMIN J is the busiest examiner, with 1 pending matter. Counsel can use centralized review to maintain consistent scientific terminology and claim support, while adapting each response to its particular examiner and art-unit setting.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
5
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
4
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (17%)
Double-patenting + other3 (50%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PACKARD, BENJAMIN J 1 67.0% +15.3%
LAU, JONATHAN S 1 63.8% -17.1%
HOERNER, PAUL ELLSWORTH 1 51.2% +62.5%
GALSTER, SAMUEL LEONARD 1 51.2% +40.2%
WORRELL, KEVIN 1 12.7% -4.0%
EASHOO, MARK 1 36.8% +36.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18661777 POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME GALSTER, SAMUEL LEONARD —
18640023 POLYURETHANE POLYMERS COMPRISING POLYSACCHARIDES WORRELL, KEVIN —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19117709 COMPOSITIONS COMPRISING WATER, CATIONIC ALPHA-1,6-GLUCAN ETHER, AND ORGANIC SOLVENT PACKARD, BENJAMIN J —
18716169 COMPOSITIONS COMPRISING CATIONIC ALPHA-GLUCAN ETHERS IN AQUEOUS POLAR ORGANIC SOLVENTS HOERNER, PAUL ELLSWORTH —
18661777 POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME GALSTER, SAMUEL LEONARD —
18557601 COMPOSITIONS COMPRISING OXIDIZED INSOLUBLE ALPHA-GLUCAN EASHOO, MARK —

Top Art Units

Art UnitApps
1693 2
1612 1
1611 1
1789 1
1742 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19117709 COMPOSITIONS COMPRISING WATER, CATIONIC ALPHA-1,6-GLUCAN ETHER, AND ORGANIC SOLVENT PACKARD, BENJAMIN J 1612 §103DP Non-Final OA — Pending Apr 02, 2025
18772616 PROCESS FOR MAKING POLYACRYLONITRILE FIBERS LAU, JONATHAN S 1693 §103Other Non-Final OA — Pending Jul 15, 2024
18716169 COMPOSITIONS COMPRISING CATIONIC ALPHA-GLUCAN ETHERS IN AQUEOUS POLAR ORGANIC SOLVENTS HOERNER, PAUL ELLSWORTH 1611 §103DP Non-Final OA — Pending Jun 04, 2024
18661777 POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME GALSTER, SAMUEL LEONARD 1693 §102§103Other Non-Final OA — Pending May 13, 2024
18640023 POLYURETHANE POLYMERS COMPRISING POLYSACCHARIDES WORRELL, KEVIN 1789 §103§112 Final Rejection — Pending Apr 19, 2024
18557601 COMPOSITIONS COMPRISING OXIDIZED INSOLUBLE ALPHA-GLUCAN EASHOO, MARK 1742 §103§112DP Non-Final OA — Pending Oct 27, 2023

Managing Nutrition & Biosciences USA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Nutrition & Biosciences USA have?

Nutrition & Biosciences USA has 6 pending office actions as of November 2026, spread across 5 art units and 6 examiners.

Which USPTO examiner handles the most Nutrition & Biosciences USA applications?

Benjamin J Packard has the most, with 1 of Nutrition & Biosciences USA's pending office actions.

What technology area are Nutrition & Biosciences USA's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month